Listen to an in-depth conversation about the challenges facing hemp and CBD businesses with Rod Kight and Scott Hawksworth of The CBD Guide.
Category: States’ Commerce
I recently discussed hemp-derived delta-8 THC with attorneys Matt Lewis and Morgan Davis of The CBD Association, a 501(c)6) nonprofit trade association that promotes strong and viable CBD and cannabinoid industries in the United States and internationally. A video of our conversation is embedded in this post.
Kentucky had an opportunity to be a leader on delta-8 THC. Instead, and as with its prohibition on smokable hemp, Kentucky chose to stake out an official position that is not only wrongheaded from a policy standpoint but is also wrong in its legal analysis. How much longer can the Kentucky hemp industry bear the burden of these misguided official positions before succumbing to their weight?
Rod recently took part in a legal and scientific discussion of certificates of analysis and Total THC with Abundant Labs and RiskScout. Watch the video here.
This article about the new vaping laws and regulations provides a practical overview of the things that all sellers of vape products should know, including sellers of delta-8 THC, CBD, and hemp extract.
In this video podcast, Rod discusses the intersection of law and science that arises from cannabis use and driving. Traditional DUI tests are primarily oriented towards detecting alcohol impairment. Do these tests work for cannabis impairment? If not, is it possible to create cannabis-specific testing protocols, and accompanying laws and regulations, that accurately measure impairment while not unjustly criminalizing unimpaired cannabis users?
Prop 65 requires businesses to provide warnings to Californians about significant exposures to chemicals, including THC. Must hemp products containing naturally-occurring THC bear the Prop 65 warning? In this article, I contend the answer is “no”.
In this video, Rod discusses delta-8 THC, CBD and cannabis in Europe and Mexico, the role of international treaties in cannabis reform, California’s Proposition 65, and the FDA’s position on CBD, among other cannabis issues.
There are many challenges with advising clients or potential clients about ∆8, one of which is the fact that many states across the country regulate hemp, hemp-derived CBD, and ∆8 differently. As a result, there is no “one-size-fits all” answer to whether ∆8 products can be manufactured, distributed, or sold within a given state.